Skip to main content

Weather Alert

Hurricane Helene is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Antibody-Free Quantification of Serum Chromogranin a by Targeted Mass Spectrometry

Antibody-Free Quantification of Serum Chromogranin a by Targeted Mass Spectrometry

Authors: Weber DM, Yang JY, Goldman SM, Clarke NJ, Taylor SW, McPhaul MJ

Citation: Clin Chem. 2021 Oct 29;hvab191. doi: 10.1093/clinchem/hvab191. Online ahead of print.

Specialties: Endocrinology, Oncology

Download key summary

Related content

Conference Presentation
Antibody-free quantification of serum chromogranin A by targeted mass spectrometry
Publication
Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors
Test FAQ
Chromogranin A Testing
Publication
Elemental Testing Using Inductively Coupled Plasma Mass Spectrometry in Clinical Laboratories

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.